Achetez l'article neuf à prix reduit et gagnez 203 €
Editeur : KARGER
Collection : Developments in Ophthalmology - 55
Année : 11/2015From basic research to therapyThe use of pharmacotherapeutics in the management of retinal diseases is rapidly evolving, and a favorable therapy for the patient. Today anti-VEGF agents are used for a range of indications from inflammation-related choroidal neovascularization to macular edema secondary to retinal vein occlusion or diabetic retinopathy.
[lire la quatrième du livre Retinal Pharmacotherapeutics]